A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale.

Saved in:
Bibliographic Details
Title: A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale.
Authors: Spiera R; Weill Cornell Medical College, New York City, NY, USA. SpieraR@hss.edu., Khanna D; University of Michigan Scleroderma Program, Ann Arbor, MI, USA., Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan., Furst DE; Department of Rheumatology, University of California in Los Angeles, CA, USA., Frech TM; University of Utah and Salt Lake City VA Health Care System Salt Lake City, UT, USA., Hummers L; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Stevens W; Department of Rheumatology, St Vincent's Hospital, Melbourne, Victoria, Australia., Matucci-Cerinic M; Department of Experimental Rheumatology, University of Florence and Division of Rheumatology AOUC, Florence, Italy., Baron M; Division of Rheumatology, Jewish General Hospital, Montreal, Canada., Distler O; Department of Rheumatology, University Hospital Zurich, Switzerland., Dgetluck N; Corbus Pharmaceuticals, Inc. Norwood, MA, USA., Bloom BJ; Corbus Pharmaceuticals, Inc. Norwood, MA, USA., Dinh Q; Corbus Pharmaceuticals, Inc. Norwood, MA, USA., White B; Corbus Pharmaceuticals, Inc. Norwood, MA, USA., Denton CP; UCL Centre for Rheumatology and Connective Tissue Diseases, Royal Free Campus, University College London, UK.
Source: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2021 Jul-Aug; Vol. 39 Suppl 131 (4), pp. 124-133. Date of Electronic Publication: 2021 Jul 21.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0392-856X
DOI:10.55563/clinexprheumatol/i80zh7